The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB‐12(®) in infant colic: A randomised, double blind, placebo‐controlled trial

BACKGROUND: The pathogenesis of infant colic is poorly defined. Gut microbiota seems to be involved, supporting the potential therapeutic role of probiotics. AIMS: To assess the rate of infants with a reduction of ≥50% of mean daily crying duration after 28 days of intervention with the probiotic Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nocerino, Rita, De Filippis, Francesca, Cecere, Gaetano, Marino, Antonio, Micillo, Maria, Di Scala, Carmen, de Caro, Carmen, Calignano, Antonio, Bruno, Cristina, Paparo, Lorella, Iannicelli, Anna M., Cosenza, Linda, Maddalena, Ylenia, della Gatta, Giusy, Coppola, Serena, Carucci, Laura, Ercolini, Danilo, Berni Canani, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973258/
https://www.ncbi.nlm.nih.gov/pubmed/31797399
http://dx.doi.org/10.1111/apt.15561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973258/
https://www.ncbi.nlm.nih.gov/pubmed/31797399
http://dx.doi.org/10.1111/apt.15561

Ejemplares similares